AI Article Synopsis
- Sphingolipids have potential to help prevent metabolic syndrome (MetS), based on research using mouse models with different diets.
- Mice fed diets enriched with certain types of sphingolipids showed improvements in body fat, insulin resistance, inflammation, and colon health after 5 weeks.
- The C16-NHGIPC-enriched diet was especially effective for colon barrier function, indicating that the structure of sphingolipids might play a role in their health benefits.
Article Abstract
Sphingolipids appear as a promising class of components susceptible to prevent the onset of the metabolic syndrome (MetS). Gut availability and effects of sphingolipids were investigated in a mouse model of dietary-induced MetS. Seed meals from two lines enriched, respectively, in C24- and C16-NH glycosyl-inositol-phosphoryl-ceramides (NHGIPC) were used in hypercaloric diets. After 5 weeks on these two hypercaloric diets, two markers of the MetS were alleviated (adiposity and insulin resistance) as well as inflammation markers and colon barrier dysfunction. A more pronounced effect was observed with the C16-NHGIPC-enriched HC diet, in particular for colon barrier function. Despite a lower digestibility, C16-NHGIPC were more prevalent in the intestine wall. Sphingolipids provided as camelina meal can therefore counteract some deleterious effects of a hypercaloric diet in mice at the intestinal and systemic levels. Interestingly, these beneficial effects seem partly dependent on sphingolipid acyl chain length.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jafc.9b06829 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!